Results 201 to 210 of about 361,864 (351)
ABSTRACT Background: This study aims to identify genes with a high likelihood of genetic variation, significant expression differences, and prognostic implications in colorectal cancer (CRC) patients. The research also seeks to investigate the role and mechanisms of key genes in CRC through the analysis of health information data and a combination of ...
Kaobin Ouyang +3 more
wiley +1 more source
Catatonia in Systemic Lupus Erythematosus. [PDF]
Manzo C, Serra-Mestres J, Isetta M.
europepmc +1 more source
CASE OF EPITHELIOMA COMPLICATING LUPUS ERYTHEMATOSUS TREATED BY SCRAPING AND HEALED BY THE X RAYS [PDF]
G. G. S. Taylor
openalex +1 more source
Aims Adherence to disease‐modifying antirheumatic drugs (DMARDs) has been associated with improved treatment outcomes, but how adherence is reported ranges between studies. We therefore aimed to determine how nonadherence to DMARDs used to treat rheumatoid arthritis (RA) has been measured and to report the nonadherence rate with each measure identified.
Lauren Fraser +7 more
wiley +1 more source
Systemic Lupus Erythematosus in Pregnancy. [PDF]
Gerede A +8 more
europepmc +1 more source
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun +4 more
wiley +1 more source
Two Cases of Lupus Erythematosus of Unusual Extent. [PDF]
E. G. Graham Little
openalex +1 more source
Harnessing chimeric antigen receptor macrophages against solid tumors
Abstract Macrophages are prevalent in multiple tumors and exhibit diverse and potent functional activities. Therapeutic reprogramming of macrophage phenotypes represents a promising strategy for cancer immunotherapy. Engineering chimeric antigen receptors (CARs) to endow macrophages with anti‐tumor capacities demonstrated encouraging efficacy ...
Mengru Wang +3 more
wiley +1 more source

